EverImmune Initiates Phase I Clinical Trial for Its Oncobiotic Drug Candidate in Lung and Kidney Cancer | DNA RNA and CellsBy Publishing TeamJanuary 16, 2023 EverImmune launches a phase I clinical trial for its oncobiotic drug candidate in lung and kidney cancer Details Category: DNA…